Insider Buying: Transenterix Inc (NASDAQ:TRXC) Director Purchases 30,000 Shares of Stock

Transenterix Inc (NASDAQ:TRXC) Director Willam N. Kelley bought 30,000 shares of Transenterix stock in a transaction dated Tuesday, August 8th. The stock was acquired at an average cost of $0.71 per share, with a total value of $21,300.00. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website.

Shares of Transenterix Inc (NASDAQ:TRXC) traded down 2.4592% during midday trading on Wednesday, hitting $0.6822. 108,401 shares of the stock were exchanged. Transenterix Inc has a 1-year low of $0.45 and a 1-year high of $2.33. The stock’s 50-day moving average price is $0.70 and its 200-day moving average price is $0.95. The firm’s market capitalization is $90.31 million.

TRADEMARK VIOLATION NOTICE: “[[title]]” was first posted by [[site]] and is the sole property of of [[site]]. If you are viewing this report on another publication, it was stolen and reposted in violation of international trademark & copyright legislation. The correct version of this report can be viewed at [[permalink]].

A hedge fund recently bought a new stake in Transenterix stock. LMR Partners LLP acquired a new stake in Transenterix Inc (NASDAQ:TRXC) during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund acquired 266,053 shares of the company’s stock, valued at approximately $189,000. LMR Partners LLP owned approximately 0.18% of Transenterix at the end of the most recent reporting period.

A number of equities research analysts have recently issued reports on TRXC shares. Zacks Investment Research raised shares of Transenterix from a “hold” rating to a “buy” rating and set a $0.75 target price for the company in a research report on Wednesday, May 10th. B. Riley cut shares of Transenterix from a “buy” rating to a “neutral” rating and set a $0.70 target price for the company. in a research report on Thursday, May 11th.

About Transenterix

TransEnterix, Inc is a medical device company. The Company is focused on the development and commercialization of ALF-X Surgical Robotic System (the ALF-X System), and SurgiBot System. The Company’s ALF-X System is a multi-port robotic surgery system, which allows multiple robotic arms to control instruments and a camera.